Cargando…
Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression
Chemoresistance represents a major obstacle in breast cancer treatment. Bone morphogenetic protein 6 (BMP6) was reported to participate in the occurrence and development of various tumors. In the present study, the results of transcriptome sequencing, qRT-PCR and western blot analysis revealed that...
Autores principales: | Luo, Xianqiang, Wang, Guohui, Wang, Yuting, Wang, Meichen, Tan, Zhuomin, Luo, Min, Zhang, Limei, Song, Yan, Jia, Yinnong, Zhou, Hongyu, Qing, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748619/ https://www.ncbi.nlm.nih.gov/pubmed/36532723 http://dx.doi.org/10.3389/fphar.2022.1059365 |
Ejemplares similares
-
Chronic exposure to the gibberellin derivative GA-13315 sensitizes breast cancer MCF-7 cells but not colon cancer HCT116 cells to irinotecan
por: Cheng, Xianliang, et al.
Publicado: (2020) -
Anti-tumor effects and mechanism of GA-13315, a novel gibberellin derivative, in human lung adenocarcinoma: an in vitro and in vivo study
por: Xie, Lin, et al.
Publicado: (2019) -
Effects and mechanism of GA-13315 on the proliferation and apoptosis of KB cells in oral cancer
por: Shen, Shan, et al.
Publicado: (2017) -
A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
por: Zhou, Xinhua, et al.
Publicado: (2019) -
Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?
por: Polimeni, Manuela, et al.
Publicado: (2014)